Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Clar

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Health Technology Assessment (Winchester, England)|March 1, 2017
Autologous chondrocyte implantation in the knee: systematic review and economic evaluationHema Mistry, Martin Connock, Joshua Pink, et al.
The Cochrane Database of Systematic Reviews|August 25, 2017
Whole grain cereals for the primary or secondary prevention of cardiovascular diseaseSarah Am Kelly, Louise Hartley, Emma Loveman, et al.
Health Technology Assessment (Winchester, England)|March 7, 2018
Corrigendum: Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluationRhona Johnston, Olalekan Uthman, Ewen Cummins, et al.
Health Technology Assessment (Winchester, England)|January 21, 2017
Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluationRhona Johnston, Olalekan Uthman, Ewen Cummins, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Health Technology Assessment (Winchester, England)|March 1, 2017
Autologous chondrocyte implantation in the knee: systematic review and economic evaluationHema Mistry, Martin Connock, Joshua Pink, et al.
The Cochrane Database of Systematic Reviews|August 25, 2017
Whole grain cereals for the primary or secondary prevention of cardiovascular diseaseSarah Am Kelly, Louise Hartley, Emma Loveman, et al.
Health Technology Assessment (Winchester, England)|March 7, 2018
Corrigendum: Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluationRhona Johnston, Olalekan Uthman, Ewen Cummins, et al.
Health Technology Assessment (Winchester, England)|January 21, 2017
Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluationRhona Johnston, Olalekan Uthman, Ewen Cummins, et al.
Pageof 3